Posts

Showing posts with the label neuro-dementia

Covid: really scary brain changes in mild cases

  A preprint, pre-peer reviewed study was done in the UK finding important changes in brain scans after Covid-19 infections, even after mild ones (see  ​ ​ covid brain mri changes medrix2021   in dropbox, or  doi.org/10.1101/2021.06.11.21258690  )     Details:   -- over 40,000 volunteers had MRI scans done prior to the Covid pandemic, stored in the UK Biobank  -- mean age 60, 43% male, 97% white, blood pressure 115/80, BMI 26  -- researchers reviewed 782 scans of people who had prior MRIs in the Biobank and second scans done on average 37 months after the initial ones:     -- 394 people with 2 scans later tested positive for Covid, and these people were matched for age, sex, ethnicity, and interval between the scans with people who did not have Covid -- 15 of these Covid patients had been hospitalized (2 in the critical care unit, 3 with ventilatory support), 379 had non-hospitalizable infections  -- the study compared the...

nonpharmacologic therapy for aggression/agitation in dementia

  A recent systematic review/network meta-analysis of randomized controlled trials found that nonpharmacologic interventions were better than pharmacologic ones for reducing aggression and agitation in adults with dementia (see dementia nonpharm rx AIM2019 in dropbox, or doi:10.7326/M19-0993. Details: -- 163 studies were included in a network meta-analysis, including 23,143 people with dementia     -- mean patient age: 70-75yo in 10%/75-80yo in 29%/>80yo in 63%; most studies had at least 50% women     -- history of neuropsychiatric symptoms in 68%, not reported in 31%     -- type of dementia: 27% Alzheimer’s, 33% multiple (e.g. Alzheimer’s and vascular dementia), 37% not reported     -- dementia severity: mild-to-moderate 11%, mild-to-moderate-to-severe 27%, moderate-to-severe 20%, not reported 34%     -- study setting: community 18%, hospital 6%, nursing home/assisted-living 65% ...

marijuana abstinence improves memory in teens

a small study in teenagers found that one week of cannabis abstenti on was associated with significant memory improvement (see  marijuana abstinence improves memory jclinpsych2018 in dropbox, or  doi-org.ezp-prod1.hul.harvard.edu/ 10.4088/JCP.17m11977 ) Details: -- 88 adolescents and young adults (age 16 to 25) who were regular cannabis users in 2015-16, from the community as well as a local high school -- 55% male, mean age 21, 14 years of education, 64% white/15% black/3% Asian/9% Hispanic, psychiatric diagnoses: 4% major depression/4% PTSD/6% generalized anxiety disorder -- baseline alcohol use in the past 90 days: 16 days of alcohol consumption, median number of drinks consumed 70 -- baseline cannabis use in past 90 days: 56 days of cannabis consumption, consumed 105 times, median consumption 26 g -- People randomly assigned to 4 weeks of cannabis abstention, verified by decreasing urinary metabolites, vs a monitored contr...

vitamin D decreases cognitive impairment

A recent article found that 12 months of vitamin D supplementation improved cognitive function in patients with mild cognitive impairment (MCI). See (see  cognitive benefit vit D jneuroetc2018  in dropbox, or doi:10.1136/ jnnp-2018-318594​ ). Details: -- 181 community dwelling patients from 6 areas in China met the inclusion criteria of being >65yo, no evident psych disorder (major depression, schizophrenia, bipolar), and MCI (as determined by the modified Petersen’s criteria: subjective memory complaint for at least 6 months, objective memory impairment for age and education (defined as being at least 1.5 SD below age- and education-matched controls on MMSE), essentially preserved ADLs, absence of dementia per DSM-IV -- mean age 67, 46% male, 18% primary school education/56% middle school/26% high school or above, 96% married, BMI 25, 7% smoking, 12% alcohol, 14% diabetes, 40% hypertension, MMSE 23 (MMSE score 18-23 signifies MCI) -- baseline...

orthostatic hypotension and dementia

Orthostatic hypotension in the elderly may be associated with incident dementia (see htn  orthostatic and cognitive impair eurheartj2018 in dropbox, or d oi.org/10.1093/eurheartj/ehy418 ). Details: --Analysis of 2316 patients in the Hypertension in the Very Elderly Trial (HYVET) cohort, a double-blind study of hypertensive patients ≥80 years, randomized to indapamide 1.5mg sustained release (long-acting thiazide-like diuretic) with optional addition of the ACE-I perindopril 2-4mg. (see htn elderly HYVET nejm 2008 in dropbox for access to HYVET) --from 90 primary and secondary centers in 13 countries --all patients had no clinical diagnosis of dementia, mean SBP of 160-199 mmHg and standing SBP ≥ 140 mmHg     --mean age 83.6, 60% female, mean sitting BP 173/91 mmHg, followed mean of 2.0  years;     --study found large reductions in stroke, death from any cause, death from cardiovascular causes, and rate of heart failure --co...